FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:803-805 September 14, 2000 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lipshultz, S. E. PubMed Citation

Mother-to-child transmission of the human immunodeficiency virus (HIV) causes a chronic and ultimately fatal pediatric infection that is now essentially preventable with antiretroviral prophylaxis. In more developed countries, prophylaxis has dramatically reduced perinatal transmission, and the potential now exists to extend this success to less developed countries by the use of effective but shorter and less expensive antiretroviral regimens. However, all regimens of antiretroviral prophylaxis require administration to the mother during pregnancy, to the neonate after birth, or both. For the large number of infants now protected from HIV infection by antiretroviral prophylaxis, the prevention of the transmission of a . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Scott, G. B. (2005). Perinatal Exposure to Antiretroviral Agents: Risks and Benefits. Am. J. Neuroradiol. 26: 689-692 [Full Text]  
• Lambert, J S, Nogueira, S A, Abreu, T, Machado, E S, Costa, T P, Bondarovsky, M, Andrade, M, Halpern, M, Barbosa, R, Perez, M (2003). A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Sex. Transm. Infect. 79: 448-452 [Abstract] [Full Text]  
• Public Health Service Task Force Perinatal HIV Gui, (2002). Summary of the Updated Recommendations From the Public Health Service Task Force to Reduce Perinatal Human Immunodeficiency Virus-1 Transmission in the United States. Obstet Gynecol 99: 1117-1126 [Abstract] [Full Text]  
• Wolf, L. E., Lo, B., Beckerman, K. P., Dorenbaum, A., Kilpatrick, S. J., Weintrub, P. S. (2001). When Parents Reject Interventions to Reduce Postnatal Human Immunodeficiency Virus Transmission. Arch Pediatr Adolesc Med 155: 927-933 [Abstract] [Full Text]  
• White, A. J (2001). Mitochondrial toxicity and HIV therapy. Sex. Transm. Infect. 77: 158-173 [Abstract] [Full Text]  
• Mandelbrot, L., Landreau-Mascaro, A., Rekacewicz, C., Berrebi, A., Benifla, J. L., Burgard, M., Lachassine, E., Barret, B., Chaix, M.-L., Bongain, A., Ciraru-Vigneron, N., Crenn-Hebert, C., Delfraissy, J.-F., Rouzioux, C., Mayaux, M.-J., Blanche, S., for the Agence Nationale de Recherches sur le SIDA, (2001). Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1. JAMA 285: 2083-2093 [Abstract] [Full Text]  
• Shetty, A. K., Maldonado, Y. (2001). HIV transmission Prevention of Perinatal HIV-1 Transmission in the United States. NeoReviews 2: e83-93 [Full Text]  
• Mofenson, L. M., the Committee on Pediatric AIDS, (2000). Technical Report: Perinatal Human Immunodeficiency Virus Testing and Prevention of Transmission. Pediatrics 106: 88e-88 [Abstract] [Full Text]